Double hit of NEMO gene in preeclampsia.

PLoS One 2017 27;12(6):e0180065. Epub 2017 Jun 27.

Department of Obstetrics and Gynecology, Polish Mother's Memorial Hospital-Research Institute in Lodz, Lodz, Poland.

The precise etiology of preeclampsia is unknown. Family studies indicate that both genetic and environmental factors influence its development. One of these factors is NFkB, whose activation depends on NEMO (NFkB essential modulator. This is the first study to investigate the association between the existence of single nucleotide variant of the NEMO gene and the appearance of preeclampsia. A total of 151 women (72 preeclamptic women and 79 controls) and their children were examined. Sanger sequencing was performed to identify variants in the NEMO gene in the preeclamptic mothers. The maternal identified variants were then sought in the studied groups of children, and in the maternal and child controls, using RFLP-PCR. Real-time RT-PCR was performed to assess NEMO gene expression in maternal blood, umbilical cord blood and placentas. The sequencing process indicated the existence of two different variants in the 3'UTR region of the NEMO gene of preeclamptic women (IKBKG:c.*368C>A and IKBKG:c.*402C>T). The simultaneous occurrence of the TT genotype in the mother and the TT genotype in the daughter or a T allele in the son increased the risk of preeclampsia development 2.59 fold. Additionally, we found that the configuration of maternal/fetal genotypes (maternal TT/ daughter TT or maternal TT/son T) of IKBKG:c.*402C/T variant is associated with the level of NEMO gene expression. Our results showed that, the simultaneous occurrence of the maternal TT genotype (IKBKG:c.*402C>T variants) and TT genotype in the daughter or T allele in the son correlates with the level of NEMO gene expression and increases the risk of preeclampsia development. Our observations may offer a new insight into the genetic etiology and pathogenesis of preeclampsia.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0180065PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487068PMC
September 2017

Publication Analysis

Top Keywords

nemo gene
28
gene expression
12
preeclamptic women
8
allele son
8
daughter allele
8
gene preeclamptic
8
level nemo
8
simultaneous occurrence
8
risk preeclampsia
8
genotype daughter
8
nemo
8
preeclampsia development
8
gene
7
maternal
6
preeclampsia
6
maternal child
4
children maternal
4
variant associated
4
studied groups
4
groups children
4

Altmetric Statistics

Similar Publications

Finding NEMO in preeclampsia.

Am J Obstet Gynecol 2016 Apr 10;214(4):538.e1-538.e7. Epub 2015 Nov 10.

Department of Obstetrics and Gynecology, Polish Mother's Memorial Hospital-Research Institute in Lodz, Poland.

Background: The mechanism of preeclampsia and its way of inheritance are still a mystery. Biochemical and immunochemical studies reveal a substantial increase in tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 concentrations in the blood of women with preeclampsia. The level of these factors is regulated by nuclear facxtor-kappa B, whose activation in a classical pathway requires inhibitory kappa B kinase gamma (known as NEMO or IKBKG). Read More

View Article and Full-Text PDF
April 2016

Placental Expression of NEMO Protein in Normal Pregnancy and Preeclampsia.

Dis Markers 2019 2;2019:8418379. Epub 2019 Jan 2.

Department of Medical Biotechnology, Medical University of Lodz, Zeligowskiego 7/9, Lodz, Poland.

Background: Preeclamptic pregnancies often present an intensified inflammatory state associated with the nuclear activity of NFB. NEMO is an essential regulator of nuclear factor kappa B (NFB) in cytoplasmic and nuclear cellular compartments. The aim of the present study is to examine the level and localization of the NEMO protein in preeclamptic and nonpreeclamptic placentas. Read More

View Article and Full-Text PDF
May 2019

Fetal Val108/158Met catechol-O-methyltransferase (COMT) polymorphism and placental COMT activity are associated with the development of preeclampsia.

Fertil Steril 2016 Jan 9;105(1):134-43.e1-3. Epub 2015 Oct 9.

Department of Physiology, School of Medicine, University of Murcia, IMIB-Arrixaca, Espinardo, Spain.

Objective: To evaluate the association between fetal and maternal catechol-O-methyltransferase (COMT) Val158Met and methyl tetrahydrofolate reductase (MTHFR) C677T functional polymorphisms and preeclampsia, examining its influence on placental COMT and in maternal 2-methoxyestradiol (2-ME) plasma levels.

Design: Prospective case-control study.

Setting: University hospital. Read More

View Article and Full-Text PDF
January 2016

MTHFR C677T and eNOS G894T variants in preeclamptic women: Contribution to lipid peroxidation and oxidative stress.

Clin Biochem 2013 Jan 24;46(1-2):143-7. Epub 2012 Oct 24.

Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Objectives: We aimed to investigate the association between methylenetetrahydrofolate reductase (MTHFR) C677T and endothelial nitric oxide synthase (eNOS) G894T polymorphisms with lipid peroxidation, total antioxidant capacity (TAC) and the risk of preeclampsia in preeclamptic women.

Design And Methods: We screened a sample of 198 unrelated women with mild and severe forms of preeclampsia and 101 unrelated women with normal pregnancy with the eNOS and MTHFR variants using PCR-RFLP method. Also, the serum malondialdehyde (MDA) and TAC levels were determined using HPLC and commercial kits, respectively. Read More

View Article and Full-Text PDF
January 2013